Mikael Eriksson

1 – 10 of 147

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/onk-mer?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
14
15
next »

2023
Mark Exposure to phenoxyacetic acids and glyphosate as risk factors for non-Hodgkin lymphoma– pooled analysis of three Swedish case-control studies including the sub-type hairy cell leukemia
Hardell, Lennart ; Carlberg, Michael ; Nordström, Marie and Eriksson, Mikael ^LU (2023) In Leukemia and Lymphoma
- Contribution to journal › Article
2022
Mark Fibrinogen-like protein 2 in gastrointestinal stromal tumour
Pulkka, Olli Pekka ; Viisanen, Leevi ; Tynninen, Olli ; Laaksonen, Maria ; Reichardt, Peter ; Reichardt, Annette ; Eriksson, Mikael ^LU ; Hall, Kirsten Sundby ; Wardelmann, Eva and Nilsson, Bengt , et al. (2022) In Journal of Cellular and Molecular Medicine 26(4). p.1083-1094
- Contribution to journal › Article
Mark SELNET clinical practice guidelines for bone sarcoma
Blay, J.Y. ; Eriksson, M. ^LU and Martin-Broto, Javier (2022) In Critical Reviews in Oncology/Hematology 174.
- Contribution to journal › Article
Mark Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Stacchiotti, Silvia ; Eriksson, M. ^LU and Wagner, A.J. (2022) In Cancer Treatment Reviews 110.
- Contribution to journal › Article
Mark SELNET clinical practice guidelines for soft tissue sarcoma and GIST
Blay, J.Y. ; Eriksson, M. ^LU and Martin-Broto, Javier (2022) In Cancer Treatment Reviews 102.
- Contribution to journal › Scientific review
2021
Mark Adjuvant imatinib for GIST : duration likely matters
Eriksson, M. ^LU and Joensuu, H. (2021) In Annals of Oncology 32(4). p.434-436
- Contribution to journal › Debate/Note/Editorial
Mark Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
Stacchiotti, S. ; Eriksson, Mikael ^LU and Trama, Annalisa (2021) In Cancer 127(16). p.2934-2942
- Contribution to journal › Article
Mark Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
Eriksson, Mikael ^LU ; Reichardt, P. ; Joensuu, H ; Krarup-Hansen, A. ; Hagberg, Oskar ^LU ; Hohenberger, P. ; Hagberg, H ; Hansson, L ; Foukakis, Theodoros and Pulkkanen, K. , et al. (2021) In ESMO Open 6(4).
- Contribution to journal › Article
Mark Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy : Results from the EUROpean Bone Over 40 Sarcoma Study
Hompland, Ivar ; Ferrari, Stefano ; Bielack, Stefan ; Palmerini, Emanuela ; Hall, Kirsten S. ; Picci, Pierro ; Hecker-Nolting, Stefanie ; Donati, Davide M. ; Blattmann, Claudia and Bjerkehagen, Bodil , et al. (2021) In European Journal of Cancer 151. p.150-158
- Contribution to journal › Article
Mark Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
Stacchiotti, S. ; Miah, A. B. ; Frezza, A. M. ; Messiou, C. ; Morosi, C. ; Caraceni, A. ; Antonescu, C. R. ; Bajpai, J. ; Baldini, E. and Bauer, S. , et al. (2021) In ESMO Open 6(3).
- Contribution to journal › Scientific review

« previous
1
2
3
4
…
14
15
next »